Daily Guru Alerts
- Dylan Jovine
- Tuesday, September 19, 2023
The Wall Street Journal calls this new drug “King Kong”…
- Dylan Jovine
- Tuesday, September 19, 2023
The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
- Dylan Jovine
- Tuesday, August 8, 2023
Lot of folks have written in to ask whether I still think Eli Lilly (SYM: LLY) is a buy up here.
- Dylan Jovine
- Wednesday, June 14, 2023
Let's start by closing out one of our older positions for a small profit.
- Dylan Jovine
- Friday, May 26, 2023
This new drug is predicted to help as many as 132 million Americans live longer, healthier and happier lives.
- Dylan Jovine
- Tuesday, May 16, 2023
Specifically, this month I’m recommending 3 stocks that are on the verge of BOOMING with new weight loss drugs hitting the market.
- Dylan Jovine
- Tuesday, September 19, 2023
The Wall Street Journal calls this new drug “King Kong”…
- Dylan Jovine
- Tuesday, September 19, 2023
The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
- Dylan Jovine
- Tuesday, August 8, 2023
Lot of folks have written in to ask whether I still think Eli Lilly (SYM: LLY) is a buy up here.
- Dylan Jovine
- Wednesday, June 14, 2023
Let's start by closing out one of our older positions for a small profit.
- Dylan Jovine
- Friday, May 26, 2023
This new drug is predicted to help as many as 132 million Americans live longer, healthier and happier lives.
- Dylan Jovine
- Tuesday, May 16, 2023
Specifically, this month I’m recommending 3 stocks that are on the verge of BOOMING with new weight loss drugs hitting the market.
deal of the month
Categories
A Warning for US Investors #shorts
Protecting Your Portfolio from the Rise of China #shorts
US Military LOSES in Simulated War Games Against China #shorts
Recent posts
Tags
Connect with Us
Get FREE Daily Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
